Cervical lesion drug trial halted early
NCT ID NCT05502367
First seen Mar 11, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This study tested an experimental vaginal insert (ABI-2280) in women with cervical precancerous lesions. The goal was to see if it was safe and could help clear abnormal cells. The trial was stopped early, and results are not yet available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL INTRAEPITHELIAL NEOPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Botho ke Bontle Health Services
Waltloo, Gauteng, 0184, South Africa
-
CerviCusco
Cusco, Peru
-
East Sydney Doctors
Darlinghurst, New South Wales, 2010, Australia
-
Farmovs
Bloemfontein, Free State, 9301, South Africa
-
Ginobs S.A.
Lima, Peru
-
Gole Biomedical Research Centre
Ga-Mothapo, Limpopo, South Africa
-
Nafasi Integrated Solutions
Sunnyside, Gauteng, 0002, South Africa
Conditions
Explore the condition pages connected to this study.